Research, innovation and quality of training courses are the cornerstones of the agreement
July 22, 2021 - Medtronic Italy, a leading provider of medical technologies, services and solutions the Università Campus Bio-Medico di Roma have signed today an agreement to promote research, innovation and the quality of training courses in the fields of biomedical engineering, medicine and life sciences.
To sign the deed, at UCBM, have been for Medtronic Italy, Michele Perrino, President and Chief Executive Officer of the company and for l 'Università Campus Bio-Medico di Roma il Rector of the University, Prof. Raffaele Calabrò and the General Director, Dr. Andrea Rossi.
The goal is to pursue ever higher standards of care from a scientific, technological, economic and social point of view with the aim of improving health care through all the tools of knowledge and expertise in the field of medical technologies, thanks to the know-how and expertise of the two realities.
The agreement signed with UCBM represents a further initiative capable of offering joint programming for a vast range of initiatives such as, for example, the national strategic doctoral program on Artificial Intelligence for Health and Life Sciences or the activation of joint laboratories (Joint- Labs) for carrying out research of common interest.
With this agreement Medtronic e Università Campus Bio-Medico di Roma they will undertake to share interventions and training contributions through the platform Make - Master Knowledge Advanced Experience – which Medtronic started three years ago and shared with numerous universities including UniSalento (Lecce), and the Federico II University of Naples. L'Università Campus Bio-Medico di Roma it will thus become a Hub connected with the offices of Mirandola, Milan, Naples and Lecce.
"Another important milestone today with Università Campus Bio-Medico di Roma - says Michele Perrino - which contributes to promoting innovation and growth in the Healthcare sector, thanks to the involvement of this prestigious university. The agreement is part of the Medtronic Open Innovation Lab project launched in 2019 which intends to support and connect biomedical hubs of excellence by combining the centers of academic and industrial knowledge to create value and facilitate synergy and growth, focusing on strong potential present in our country.
"The signing of this agreement represents a fundamental step in building our idea of a university: a place where the results of the most advanced research become tools of care capable of improving the quality of life of patients, their families and therefore of the community " – has ofchiarato Raffaele Calabrò. "We have already created a structured contact between Medtronic's professionals and the most active Research Units in the biomedical field such as those of neurology, neurophysiology and neurobiology, cardiovascular sciences, otorhinolaryngology, general surgery, endocrinology and diabetes, to study specific solutions to combat diseases that afflict large sections of the population. And thanks to this collaboration we will enhance the training and research paths of our university, aiming to achieve ever higher and more competitive standards at an international level".
